Search Within

Heiko Schoder

  1. "Steven Larson"
Formats
  1. Journal Article (57)
  2. Meeting Abstract (32)
  3. Book Section (3)
  4. Editorial (1)
Groups
  1. GSK Faculty (93)
  2. Molecular Imaging and Therapy Service (93)
  3. Molecular Pharmacology and Chemistry Program Faculty (93)
  4. Radiology, Department of (93)
  5. Sloan Kettering Institute Faculty (93)
  6. Medical Physics (46)

More Groups

People
  1. Steven Larson (93)
  2. John Humm (29)
  3. Mithat Gonen (25)
  4. Henry Yeung (22)
  5. Josef Fox (19)
  6. Sadek Nehmeh (19)

More People

Years
  1. 2025 (2)
  2. 2024 (4)
  3. 2023 (5)
  4. 2021 (1)
  5. 2020 (1)
  6. 2019 (3)

More Years

Publications
  1. Journal of Nuclear Medicine (36)
  2. Journal of Clinical Oncology (13)
  3. European Journal of Nuclear Medicine and Molecular Imaging (5)
  4. Medical Physics (5)
  5. Clinical Cancer Research (3)
  6. Annals of Surgical Oncology (2)

More Publications

Publishers
  1. Society of Nuclear Medicine (36)
  2. American Society of Clinical Oncology (13)
  3. Springer (12)
  4. American Association of Physicists in Medicine (5)
  5. Lippincott Williams & Wilkins (5)
  6. American Association for Cancer Research (4)

More Publishers

Results (93)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pathologic correlation of 18F-16 beta-fluoro-5 alpha-dihydrotestosterone (FDHT) and FDG PET in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Feldman, J. L.; Fox, J. J.; Martinez, D. F.; Autio, K. A.; Durack, J. C.; Humm, J.; Schoder, H.; Gavane, S. C.; Curtis, K. R.; Balakirsky, S. M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe
    Journal Article

    Phillips, E.; Penate-Medina, O.; Zanzonico, P. B.; Carvajal, R. D.; Mohan, P.; Ye, Y.; Humm, J.; Gonen, M.; Kalaigian, H.; Schöder, H.; more...
    Science Translational Medicine (2014)

    Fulltext@MSK | Save
  • Evaluating 18F-16 beta-fluoro-5 alpha-dihydrotestosterone (FDHT) and FDG PET as prognostic biomarkers for patients (pts) treated with abiraterone acetate (AA)
    Meeting Abstract

    Feldman, J. L.; Fox, J. J.; Autio, K. A.; Gavane, S. C.; Heller, G.; Schoder, H.; Humm, J.; Martinez, D. F.; Slovin, S. F.; Scher, H. I.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Post-treatment alterations in 18F-dihydrotestosterone (FDHT) and FDG PET/CT in metastatic castration-resistant prostate cancer (mCRPC) treated with cabozantinib
    Meeting Abstract

    Fox, J. J.; Haupt, E. C.; Humm, J.; Autio, K. A.; Rathkopf, D. E.; Vargas, H. A.; Schöder, H.; Hricak, H.; Larson, S. M.; Scher, H. I.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Evaluating 18F-16B-fluoro-5α-dihydrotestosterone (FDHT) and FDG-PET as a measure of disease progression in metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Autio, K. A.; Fox, J. J.; Schneider, C. W.; Schöder, H.; Humm, J.; Rathkopf, D. E.; Slovin, S. F.; Danila, D. C.; Haupt, E. C.; Larson, S. M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Split-dose technique for FDG PET/CT-guided percutaneous ablation: A method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness
    Journal Article

    Ryan, E. R.; Sofocleous, C. T.; Schoder, H.; Carrasquillo, J. A.; Nehmeh, S.; Larson, S. M.; Thornton, R.; Siegelbaum, R. H.; Erinjeri, J. P.; Solomon, S. B.
    Radiology (2013)

    Fulltext@MSK | Save
  • 18F-16 beta-fluoro-5 alpha-dihydrotestosterone (FDHT) PET as a prognostic biomarker for survival in patients with metastatic castrate-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Autio, K. A.; Fox, J. J.; Jia, X.; Heller, G.; Schoder, H.; Humm, J.; Haupt, E. C.; Schneider, C.; Scher, H. I.; Larson, S. M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Comparison of PSA, FDG-PET, and Prostate Cancer Working Group 2 (PCWG2) criteria to interpret apparent progression on first post-treatment bone scan
    Meeting Abstract

    Autio, K. A.; Fox, J. J.; Haupt, E. C.; Schoder, H.; Scher, H. I.; Larson, S. M.; Morris, M. J.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Initial results with (11)C-acetate positron emission tomography/computed tomography (PET/CT) in the staging of urinary bladder cancer
    Journal Article

    Schoder, H.; Ong, S. C.; Reuter, V. E.; Cai, S.; Burnazi, E.; Dalbagni, G.; Larson, S. M.; Bochner, B. H.
    Molecular Imaging and Biology (2012)

    Fulltext@MSK | Save
  • Molecular imaging of prostate cancer
    Journal Article

    Fox, J. J.; Schoder, H.; Larson, S. M.
    Current Opinion in Urology (2012)

    Fulltext@MSK | Save